Jon McNeill's Insider Trades & SAST Disclosures
Jon McNeill's most recent trade in Lululemon Athletica inc. was a trade of 503 Common Stock done . Disclosure was reported to the exchange on June 7, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jon McNeill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lululemon Athletica inc. | Jon McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 503 | 8,333 (0%) | 0% | 0 | Common Stock | |
| Dyne Therapeutics Inc | McNeill Jonathan | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,245 | 155,518 | - | 10.7 | 13,346 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 96,158 | 156,763 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 37,445 | 37,445 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 1,261 | 60,605 | - | 9.4 | 11,866 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,266 | 61,866 | - | 10.4 | 13,179 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2023 | 35,000 | 35,000 | - | - | Stock option (right to buy) | |
| Lululemon Athletica inc. | Jon McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 407 | 7,830 (0%) | 0% | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 12 Jun 2023 | 1,259 | 63,132 | - | 12.4 | 15,649 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 12 Jun 2023 | 1,000 | 64,391 | - | 13 | 13,000 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 13 Mar 2023 | 1,209 | 65,391 | - | 13.3 | 16,116 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 13 Mar 2023 | 1,000 | 66,600 | - | 13 | 13,000 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 18 Jan 2023 | 10,000 | 77,600 | - | 0.7 | 7,300 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 18 Jan 2023 | 10,000 | 67,600 | - | 14.0 | 140,300 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 10,000 | 68,528 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 11.57 per share. | 09 Jan 2023 | 30,150 | 67,600 | - | 11.6 | 348,836 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 40,000 | 98,222 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 472 | 97,750 | - | 10.9 | 5,131 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 1,246 | 58,222 | - | 13.7 | 17,070 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 494 | 59,468 | - | 14.1 | 6,941 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 21,666 | 21,666 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 504 | 59,962 | - | 5.0 | 2,495 | Common Stock |
| Lululemon Athletica inc. | Jon McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 487 | 7,423 (0%) | 0% | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 481 | 60,466 | - | 8.7 | 4,199 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 37,967 | 37,967 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 25,311 | 60,947 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 729 | 35,636 | - | 16.1 | 11,744 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 545 | 36,365 | - | 15.6 | 8,507 | Common Stock |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Lululemon Athletica inc. | Jon McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 397 | 6,936 (0%) | 0% | 0 | Common Stock | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 52,787 | 52,787 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Jonathan McNeill | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 17,012 | 36,910 | - | 0 | Common Stock | |
| Lululemon Athletica inc. | Jon McNeill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 439 | 6,539 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges